Skip to main content


Table 3 Direct cost (test and treatment cost) and comprehensive cost (including estimate of life value) of the presumptive versus the test based strategy at "real life" adherence levels to both strategies (see text): test and treatment cost not subsidized

From: Strict adherence to malaria rapid test results might lead to a neglect of other dangerous diseases: a cost benefit analysis from Burkina Faso

Variables Children, dry season Children, rainy season Adults, dry season Adults, rainy season
Direct cost, presumptive strategy 1032 1033 2005 2048
Direct cost, test-based strategy 1713 1767 2699 2758
Comprehensive cost, presumptive strategy 1747 1372 2728 2604
Comprehensive cost, test-based strategy 2615 2284 3369 3271
Threshold life value* n.a. (test dominated) n.a. (test dominated) 6958 9071
  1. Costs expressed in € (euro) for 1000 patients managed with either strategy, assuming a life value of 525 € (better option in bold)
  2. * Life value at which the two strategies become equivalent at sensitivity analysis